Learn more

AFFINA IMMUNTECHNIK GMBH

Overview
  • Total Patents
    22
About

AFFINA IMMUNTECHNIK GMBH has a total of 22 patent applications. Its first patent ever was published in 1996. It filed its patents most often in Germany, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and chemical engineering are FORERUNNER PHARMA RES CO LTD, GENEPROT INC and TRELLIS BIOSCIENCE INC.

Patent filings in countries

World map showing AFFINA IMMUNTECHNIK GMBHs patent filings in countries

Patent filings per year

Chart showing AFFINA IMMUNTECHNIK GMBHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kunze Rudolf 14
#2 Roenspeck Wolfgang 13
#3 Wallukat Gerd 7
#4 Dierenfeld Manuela 6
#5 Egner Ralf 4
#6 Mueller Johannes 3
#7 Schroedl Wieland 3
#8 Ronspeck Wolfgang 3
#9 Wrede Paul 3
#10 Schneider Gisbert 3

Latest patents

Publication Filing date Title
AU2002302410A1 Method for identifying immune reactive epitopes on proteins
WO0238592A2 Peptides, the production and use thereof for binding immunoglobulins
AU2057702A Circulatory device for separating substances in bodily fluids, especially blood,and the use of said device
DE10131426A1 Heat pasteurization of immunoglobulin Y, e.g. for pharmaceutical use, using specific temperature and time conditions allowing inactivation of viruses while retaining antibody activity
DE10131425A1 Extracting immunoglobulin Y from egg yolk, useful as diagnostic or therapeutic antibodies, by dilution in water, is simple and provides high yields
WO0121660A1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm)
DE19945211A1 New autoantibody-binding peptides with an amino acid sequence corresponding a beta1-adrenergic receptor group useful for treating dilatative cardiomyopathy
EP1086954A1 Peptides against autoantibodies elicited by DCM
EP1086955A1 Peptides against antibodies elicited by DCM
DE19945210A1 New autoantibody-binding peptides with an amino acid sequence corresponding a beta1-adrenergic receptor group, useful for treating dilatative cardiomyopathy
EP1082339A2 Rationally designed peptides, production and use thereof
DE19826442A1 Rationally designed peptides, their production and their use
DE19818790A1 Preparation of an immuno-adsorption matrix, useful for diagnostic and therapeutic purposes
DE19653669A1 Immuno-adsorbent for removing immunoglobulin(s) from biological fluids